Table 1 Correlation between ACSL4 expression and clinicopathological characteristics of ESCC
Characteristics | ESCC (n = 90) | Percent | ACSL4 | P value | |
|---|---|---|---|---|---|
Low (n = 45) | High (n = 45) | ||||
Gender | Â | Â | Â | Â | 0.141 |
Male | 68 | 75.56% | 31 (68.89%) | 37 (82.22%) | Â |
Female | 22 | 24.44% | 14 (31.11%) | 8 (17.78%) | Â |
Age (29–84) |  |  |  |  | 0.026 |
>65.81 | 46 | 51.11% | 28 (62.22%) | 18 (40%) | Â |
<65.81 | 43 | 47.78% | 16 (35.56%) | 27 (60%) | Â |
Missing | 1 | 1.11% | 1 (2.22%) | Â | Â |
Pathological grade | Â | Â | Â | Â | 0.034 |
I | 8 | 8.89% | 7 (15.56%) | 1 (2.22%) | Â |
II | 66 | 73.33% | 33 (73.33%) | 33 (73.33%) | Â |
III | 16 | 17.78% | 5 (11.11%) | 11 (24.44%) | Â |
Tumor volume (mm3) | Mean value | 25.91 | 24.11 | 27.88 | Â |
Lymph node | Mean value | 1.82 | 1.29 | 2.37 | Â |
pT status | Â | Â | Â | Â | 0.590 |
T1 | 3 | 3.33% | 1 (2.22%) | 2 (4.44%) | Â |
T2 | 15 | 16.67% | 6 (13.33%) | 9 (20%) | Â |
T3 | 67 | 74.44% | 35 (77.78%) | 32 (71.11%) | Â |
T4 | 1 | 1.11% | 0 (0%) | 1 (2.22%) | Â |
Missing | 4 | 4.44% | 3 (6.67%) | 1 (2.22%) | Â |
Pathomorphology | Â | Â | Â | Â | 0.237 |
Medullary type | 23 | 25.56% | 14 (31.11%) | 9 (20%) | Â |
Ulcerative type | 46 | 51.11% | 21 (46.47%) | 25 (55.56%) | Â |
Mushroom umbrella type | 5 | 5.56% | 4 (8.89%) | 1 (2.22%) | Â |
others | 16 | 17.78% | 6 (13.33%) | 10 (22.22%) | Â |
